title: Intestinal amoebiasis in a patient with acute graft-versus-host disease after allogeneic bone marrow transplantation successfully treated by metronidazole.
abstract: Amoebiasis has rarely been reported in patients undergoing hematopoietic stem cell transplantation, although it is a world-wide infection and extremely common. We present a case of intestinal amoebiasis unexpectedly revealed by colonoscopy after allogeneic bone marrow transplantation from a human leukocyte antigen-mismatched unrelated donor for acute myeloid leukemia arising from chronic myelomonocytic leukemia and successfully treated by metronidazole.
authors.affiliation: Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan.
authors.forename: A
authors.initials: A
authors.lastname: Numata
authors.affiliation: Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan.
authors.forename: M
authors.initials: M
authors.lastname: Itabashi
authors.affiliation: Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Kishimoto
authors.affiliation: Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Motohashi
authors.affiliation: Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan.
authors.forename: M
authors.initials: M
authors.lastname: Hagihara
authors.affiliation: Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Kuwabara
authors.affiliation: Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan.
authors.forename: M
authors.initials: M
authors.lastname: Tanaka
authors.affiliation: Infection Control Department, Yokohama City University Medical Center, Yokohama, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Kato
authors.affiliation: Department of Pathology, Yokohama City University Medical Center, Yokohama, Japan.
authors.forename: S
authors.initials: S
authors.lastname: Chiba
authors.affiliation: Inflammatory Bowel Disease Center, Yokohama City University Medical Center, Yokohama, Japan.
authors.forename: R
authors.initials: R
authors.lastname: Kunisaki
authors.affiliation: Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan.
authors.forename: S
authors.initials: S
authors.lastname: Fujisawa
mesh_terms: D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D004404:Dysentery, Amebic / Q000188:drug therapy* / Q000209:etiology; D006086:Graft vs Host Disease / Q000150:complications*; D006801:Humans; D016867:Immunocompromised Host; D008297:Male; D008795:Metronidazole / Q000627:therapeutic use*; D008875:Middle Aged
chemical_list: D000981:Antiprotozoal Agents; D008795:Metronidazole
keywords: Entamoeba histolytica; HSCT; bone marrow transplantation; intestinal amoebiasis